Neuropace Inc (NPCE)

NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare Conference - Quantisnow

Quantisnow

NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri ... - Quantisnow

Quantisnow

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference - Quantisnow

Quantisnow

NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference - Quantisnow

Quantisnow

NeuroPace to Present at the Morgan Stanley 20th Annual Global Healthcare Conference - Quantisnow

Quantisnow

NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference - Quantisnow

Quantisnow

NeuroPace Announces First Patient Implanted in NAUTILUS Pivotal Study for the Treatment of Idiopathic Generalized ... - Quantisnow

Quantisnow

Institutions profited after NeuroPace, Inc.'s (NASDAQ:NPCE) market cap rose US$25m last week but private equity firms profited the most - Simply Wall St

Simply Wall St

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

MarketBeat

NeuroPace, Inc. (NASDAQ:NPCE) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

Defense World

NeuroPace (NASDAQ:NPCE) adds US$17m to market cap in the past 7 days, though investors from a year ago are still ... - Yahoo Movies Canada

Yahoo Movies Canada

Financial Review: iRhythm Technologies (NASDAQ:IRTC) vs. NeuroPace (NASDAQ:NPCE) - Defense World

Defense World

BCI and SEEG Market is expected to represent Significant CAGR by 2031 | NeuroPace Inc, Mindmaze SA, G.TEC ... - TIMC

TIMC

Further Upside For NeuroPace, Inc. (NASDAQ:NPCE) Shares Could Introduce Price Risks After 39% Bounce - Yahoo New Zealand News

Yahoo New Zealand News

Can you still get a good price for NeuroPace Inc (NPCE) Shares at this point? – US Post News - US Post News

US Post News

Recent Insider Activity Suggests Potential Gains for NeuroPace Inc (NPCE) – Knox Daily - Knox Daily

Knox Daily

Further Upside For NeuroPace, Inc. (NASDAQ:NPCE) Shares Could Introduce Price Risks After 39% Bounce - Yahoo New Zealand News

Yahoo New Zealand News

Brain Computer Interfaces in Medicine Market Business Insights, Key Trend Analysis | NeuroPace Inc, Mindmaze SA, G ... - Amoré

Amoré

NeuroPace, Inc. (NASDAQ:NPCE) Sees Significant Decrease in Short Interest - MarketBeat

MarketBeat

Objective long/short (NPCE) Report - Stock Traders Daily

Stock Traders Daily

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com

Investing.com

Neuroprosthetics Market Expected to Surge with 10.9% CAGR, - openPR

openPR

NeuroPace, Inc. (NASDAQ:NPCE) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

Defense World

NeuroPace, Inc. (NASDAQ:NPCE) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

MarketBeat

NeuroPace (NASDAQ:NPCE) vs. Accuray (NASDAQ:ARAY) Financial Contrast - Defense World

Defense World

NeuroPace (NASDAQ:NPCE) vs. Accuray (NASDAQ:ARAY) Financial Contrast - Defense World

Defense World

Wells Fargo maintains Overweight on NeuroPace with $20 target - Investing.com India

Investing.com India

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com Australia

Investing.com Australia

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com

Investing.com

Wells Fargo maintains Overweight on NeuroPace with $20 target By Investing.com - Investing.com

Investing.com

NeuroPace to Present at 40th Annual J.P. Morgan Healthcare Conference - The Globe and Mail

The Globe and Mail

Market Watch Highlights: NeuroPace Inc (NPCE) Ends on an Downturn Note at 7.53 – DWinneX - The Dwinnex

The Dwinnex

NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions - Yahoo Finance UK

Yahoo Finance UK

NeuroPace, Inc.'s (NASDAQ:NPCE) top owners are private equity firms with 47% stake, while 24% is held by institutions - Yahoo Finance

Yahoo Finance

Trend Tracker for (NPCE) - Stock Traders Daily

Stock Traders Daily

Bear of the Day: NeuroPace (NPCE) - Yahoo New Zealand News

Yahoo New Zealand News

Contrasting Tactile Systems Technology (NASDAQ:TCMD) and NeuroPace (NASDAQ:NPCE) - Defense World

Defense World

NeuroPace (NPCE) Price Target Increased by 17.52% to 9.35 - MSN

MSN

NeuroPace (NASDAQ:NPCE) adds US$17m to market cap in the past 7 days, though investors from a year ago are still ... - Yahoo Movies UK

Yahoo Movies UK

NeuroPace to Participate in Two Healthcare Conferences in May - Investing.com India

Investing.com India

Q2 2024 Earnings Forecast for NeuroPace, Inc. (NASDAQ:NPCE) Issued By Leerink Partnrs - MarketBeat

MarketBeat

Brain Computer Interface Technology Market 2024 Trends with Analysis on Key Players NeuroPace Inc, Emotiv Inc ... - Amoré

Amoré

NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Insider Monkey

Insider Monkey

NeuroPace's (NPCE) Overweight Rating Reaffirmed at Cantor Fitzgerald - Defense World

Defense World

NeuroPace, Inc. (NASDAQ:NPCE) Q1 2024 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

Q2 2024 EPS Estimates for NeuroPace, Inc. Decreased by Analyst (NASDAQ:NPCE) - Defense World

Defense World

Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion By Investing.com - Investing.com Canada

Investing.com Canada

Earnings call: NeuroPace sees strong Q1 revenue growth, eyes RNS system expansion - Investing.com India

Investing.com India

FY2028 Earnings Estimate for NeuroPace, Inc. Issued By Leerink Partnrs (NASDAQ:NPCE) - Defense World

Defense World